The PPRI Secretariat produced an up-to-date concise report of the pharmaceutical system in Cyprus: The “PPRI Pharma Brief Cyprus 2021” describes on a few pages the institutional policy framework…
We aim to contribute to affordable, equitable and sustainable access to safe, effective and quality essential medicines in Austria, Europe and globally.
Publication of the PPRI Pharma Brief Cyprus 2021
Article on Biosimilar Policies in Europe
Based on information surveyed from the Pharmaceutical Pricing and Reimbursement Information (PPRI) network, an overview on policies to enhance the uptake of biosimilar medicines in European countries…
Comparison of Prices and Affordability in Latin America and Europa
This study compared public procurement and ex-factory prices for 19 cancer medicines in five Latin American countries (Brazil, Chile, Colombia, Mexico, and Peru) and 11 European countries (Austria,…